Upload the DNA data file of the test

23andMe, AncestryDNA, FamilyTreeDNA, MyHeritage

and get an enhanced
personalized health report
free without registration

Files accepted .txt, .csv, .zip, .csv.gz

File data is not stored on the server

Hepatitis DNA health report

Follow the link of the selected polymorphism to read a brief description of how the selected polymorphism affects Hepatitis and see a list of existing studies.

SNP polymorphisms related to the topic Hepatitis:

rs3077A common HLA-DPA1 variant increases the risk of chronic hepatitis B 1.8-fold.
rs187238
rs738409The rs738409 polymorphism in PNPLA3 is associated with the risk of liver damage and the development of non-alcoholic fatty liver disease. It influences the progression of fibrosis and steatosis in chronic hepatitis C.
rs1127354ITPA gene variant reduces the risk of anaemia due to anti-HCV therapy with rivarin.
rs1946518Interleukin (IL)-18 polymorphism is associated with chronic hepatitis C and B virus infections.
rs2254135
rs2856718HLA-DQB1 polymorphisms are associated with susceptibility to chronic hepatitis B.
rs7224000
rs7270101The ITPA gene variant protects against ribavirin-induced haemolytic anaemia and reduces the need for ribavirin dose reduction in hepatitis C virus treatment.
rs7453920Association of HLA-DQB1 breakage variant with susceptibility to chronic hepatitis B. Direct effect on the risk of hepatitis B virus infection in children.
rs7756516HLA-DQB2 single nucleotide polymorphism associated with hepatitis B.
rs8099917The major polymorphism rs8099917 of the IL28B gene predicts treatment outcomes in patients infected with hepatitis C virus. Associated with ineffectiveness of interferon-alpha and ribavirin therapy in chronic hepatitis C. However, at the same time, there are known cases of spontaneous cure from hepatitis C by carriers of this defect.
rs8103142IL28B genetic variability is associated with spontaneous HCV elimination, response to treatment, and blood levels of IL-28B.
rs8105790
rs9276370MHC locus and genetic susceptibility to persistent hepatitis B virus infection.
rs9277535The chronic hepatitis B risk allele is associated with reduced expression of HLA-DPA1 and HLA-DPB1 mRNA in normal human liver. Allows prediction of recovery from hepatitis B virus infection. Also affects both hepatitis C virus persistence and hepatitis C virus F protein formation.
rs9366816Polymorphisms influence the risk of hepatitis B virus infection.
rs10789491
rs11697186Polymorphism causing the risk of thrombocytopenia during pegylated interferon and ribavirin therapy for chronic hepatitis C.
rs11725957
rs12979860A variant of the gene encoding interferon-lambda-4 (IFN-lambda-4) predicts virus elimination induced by hepatitis C treatment. It is associated with an approximately twofold change in response to treatment with pegylated interferon-alpha (PEG-IFN-alpha) in combination with ribavirin (RBV).
rs12980275IL28B polymorphism associated with response to therapy in patients with chronic hepatitis C on the outcome of dual combination therapy for chronic hepatitis C virus infection. But also associated with spontaneous disappearance of HCV infection.
rs16864968
rs17067123
en
|
de
|
fr
|
es
|
it
|
ua
|
ru

Support

-